Státní ústav pro kontrolu léčiv — State Institute for Drug Control of the Czech Republic
SÚKL CZ · Czech Republic · europe
Czech Republic's State Institute for Drug Control — leeches fall under EU medical-device frameworks (MDR 2017/745) as implemented through Czech national law; leech-specific national authorisation has not been independently verified by ASH.
Regulatory Profile
- Agency type
- national regulator
- Region
- europe
- Country
- Czech Republic
- Leech status
- unregulated
- Last ASH review
- 2026-05-27
- Website
- https://www.sukl.cz
Relevant Regulation Codes
- Czech Act No. 378/2007 on Pharmaceuticals (Zákon o léčivech), as amended
- EU Medical Device Regulation (MDR) 2017/745 — as transposed into Czech law (Act No. 89/2021)
- Czech Act No. 268/2014 on Medical Devices, as amended
Prescriber Requirements
- Czech Medical Chamber (Česká lékařská komora)–registered physician — order required for any biomedical device application
- Allied health professional application under physician supervision per institutional protocol
Supply Chain & GMP
SÚKL registration as applicable; Czech-language labelling required by national law. Standard cold-chain conditions; EU intra-community movement under MDR applies.
Import/Export Rules
Free movement within the EU single market under MDR; State Veterinary Administration clearance for live invertebrates from non-EU origin; CITES Appendix II paperwork for Hirudo medicinalis / verbana on extra-EU import.
Reimbursement Context
General Health Insurance Company (VZP ČR) and other public payers may cover inpatient bundled use; outpatient hirudotherapy is generally not separately reimbursed.
ASH Editorial Notes
Leech-specific pathway not independently verified by ASH; falls under general EU MDR framework as transposed into Czech law. SÚKL coordinates with EMA and other EU NCAs; the historical-clinical reception of hirudotherapy in Central European medicine is rich, but whether contemporary leech-specific guidance exists has not been independently mapped by ASH.
Related Jurisdictions
EMA — European Union
Centralised EU authority for medicinal products — leeches sit on the border between MDR-regulated device and HMPC traditional herbal medicine framework.
European Commission — European Union
EU executive body responsible for the Medical Device Regulation (MDR) — the legal instrument that frames how Member States CE-mark leech products.
MHRA — United Kingdom
Post-Brexit UK regulator — accepts EU CE marks during transition, with UKCA marking now phased in for Great Britain (Northern Ireland follows EU MDR via Windsor Framework).
BfArM — Germany
Germany classifies medicinal leeches as a finished medicinal product (Fertigarzneimittel) — uniquely strict among EU Member States and requires marketing authorisation via BfArM.